Research Peptide SKU: EU-SELANK

Selank

≥98% Purity Class-level spec; selected lots third-party tested
COA Available Batch report on request · HPLC identity check
Size 10mg = Lab report published

€39.99

1

Total: €39.99

Unavailable

Free shipping on orders over €200

  • If a product does not match the specification on its published COA, contact us with your batch number: we investigate against the lot report and replace any product that fails it, at no cost to you.
  • Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

3–7 days most of the EU · 10–14 Nordics/Baltics

Standard EU from €4.99 · core EU GLS €17.99 · Dispatched within 1–2 business days · Free shipping over €200 · no customs paperwork (EU).

How Paysera and SEPA work

  1. Pay: send a manual SEPA transfer using the IBAN we email you, or approve a SEPA transfer via Paysera where offered.
  2. We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
  3. We dispatch — confirmed orders typically ship within 1–2 business days.

Card payments are not currently offered.

Research-grade Selank peptide for laboratory applications. For research purposes only. Not for human consumption.

Volume Pricing Applied automatically at checkout
Quantity Price Each Total Savings
1 unit €39.99 €39.99 —
3+ €37.99 €113.97 5% off
10+ €33.99 €339.92 15% off
Published reports

Laboratory reports are available for selected lots. Check each report for its result and stated method.

Third-Party Tested

Class-level specification on record; independent testing on selected lots.

Fast Shipping

Dispatched within 1–2 business days, shipping from €4.99 in the EU.

EU Dispatch

Ships across the EU plus Switzerland and the UK where permitted.

Last reviewed: 2026-11-03

Selank Peptide 10mg

Selank 10 mg is a research peptide supplied as a lyophilised powder, a tuftsin analogue, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Formula C₃₃H₅₇N₁₁O₉, molar mass about 751.9 g/mol. Published studies of the compound have examined behavioural responses linked to anxiety and stress, attention, short-term memory, and GABAergic signalling. That work concerns the compound as studied, not this vial, and it is not a dosing guide. Selank is not Semax: they share only the Pro-Gly-Pro segment. For laboratory research only. Not for human or veterinary administration.

 

Product detail Information to confirm
Presentation Sealed vial containing 10mg of lyophilised material
Purity Result reported on the batch-specific certificate of analysis
Traceability Agreement between the product label and analytical records
Availability Current price, stock and dispatch arrangements

What Is Selank?

Selank is a synthetic peptide analogue of tuftsin, with the seven-residue sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its molecular structure contains the tuftsin sequence followed by a Pro-Gly-Pro extension. This defined composition provides a basis for analytical characterisation and experimental comparisons. 

Characteristic Detail
Molecular formula C₃₃H₅₇N₁₁O₉
Molecular weight Approximately 751.9 g/mol
Classification Tuftsin analogue
Sequence length Seven amino acids

Confirm whether the supplied product is the free peptide or a salt form, as this distinction can affect molecular calculations and interpretation of the labelled quantity.

What the Research Has Investigated

Selank has been investigated in experiments involving neurotransmission, gene expression and behavioural responses. These studies provide questions for further laboratory work, rather than establishing that the supplied research peptide produces therapeutic effects.

Experiments should distinguish a measured signal from the broader biological conclusions drawn from it. Changes in gene expression, for example, do not automatically demonstrate improved cognition or a predictable behavioural response.

GABAergic Signalling

Studies in rat tissue and cultured cells have examined changes in genes associated with GABAergic neurotransmission after exposure to Selank. These findings support investigation of the peptide’s relationship with inhibitory signalling, while leaving aspects of its mechanism unresolved. 

Molecular Interactions

Research has also examined interactions involving GABA binding and the combined effects of Selank with other compounds. Such experiments require appropriate controls to distinguish the peptide’s individual activity from responses observed with a combination. Findings remain dependent on the model, concentration and measurements used. 

Interpreting Experimental Outcomes

For research purposes, record exposure conditions, sample preparation and the methods used to measure each signal. A clear protocol helps researchers assess whether results are reproducible and whether comparisons with published work are appropriate.

Limitations of the Evidence

The available literature does not fully establish Selank’s mechanism or justify broad claims about cognitive enhancement, immune function or clinical effectiveness. Animal behaviour, isolated-cell responses and biochemical measurements answer different questions and should not be presented as interchangeable evidence.

The research use designation of a commercial product also does not demonstrate equivalence to material used in a published experiment. Identity, composition and preparation conditions must be assessed separately.

Distinction from Semax

Selank and Semax are different compounds and should not be substituted for one another in a protocol. Although both contain a Pro-Gly-Pro terminal sequence, their remaining amino acids differ.

A shared structural feature does not establish identical molecular targets or experimental outcomes. Choose the peptide that matches the research question and verify its complete identity before making comparisons.

Quality and Analysis

For Selank 10mg, review the certificate of analysis supporting the stated purity. HPLC results can help assess the sample’s analytical profile, while suitable identity testing provides separate evidence about the material supplied.

A reported purity percentage does not independently confirm peptide quantity, sterility or the absence of contaminants. Claims about heavy metals, endotoxins or independent testing should be supported by the relevant reports rather than inferred from an HPLC result.

Storage and Reconstitution

Follow the supplier’s documented conditions for the lyophilised material. Before reconstitution, confirm the solvent, target concentration and preparation method required by your laboratory protocol.

Record reconstitution details and follow product-specific instructions for prepared solutions. Do not assume that the stability of the dried peptide establishes a universal shelf life after preparation.

Ordering and Intended Use

Before you buy Selank, confirm that the available documentation meets your institution’s requirements. This product is supplied strictly for laboratory investigation and research use only.

It is not intended for human or veterinary administration, consumption, diagnostic procedures or treatment. Qualified personnel should follow institutional procedures for receipt, handling, storage and disposal.

Related Studies